Goldman Sachs is out with its report today on Tempur-Pedic International TPX, initiating TPX at Neutral.
In its report, Goldman Sachs writes, "We initiate coverage of Tempur-Pedic, the premier specialty bedding maker, with a Neutral rating and a $66, six-month price target. We have a positive view on its long-term earnings trajectory, driven by market share
gains within specialty bedding, a focus on margin-expanding cost cuts and share repurchases (31% of outstanding shares have been bought back since 2005). However, TPX is at a relatively mature point in its
growth cycle and our analysis suggests that we should wait for a more favorable risk/reward to take advantage of the long-term positives."
Shares of TPX closed Monday at $62.81, down 0.82% from Friday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in